Literature DB >> 9470407

Comparison of broth macrodilution, broth microdilution and E-test susceptibility tests of Cryptococcus neoformans for fluconazole.

E Chryssanthou1, C Grönfors, N Khanna.   

Abstract

Forty Cryptococcus neoformans strains isolated from cerebral spinal fluid specimens collected from 39 patients were included in the study. The MICs for fluconacole were determined by YNB macrodilution test, microdilution tests using both RPMI1640 and YNB medium and E-tests on solidified RPMI1640 medium, Casitone and YNB agar. In comparison with the reference macrodilution method NCCLS M27-P both the microdilution as well as the E-test techniques can be used for fluconacole susceptibility testing of Cr. neoformans.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9470407     DOI: 10.1111/j.1439-0507.1997.tb00179.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  3 in total

1.  Comparative analysis of the Vitek 2 antifungal susceptibility system and E-test with the CLSI M27-A3 broth microdilution method for susceptibility testing of Indian clinical isolates of Cryptococcus neoformans.

Authors:  Aarti Tewari; Bijayani Behera; Purva Mathur; Immaculata Xess
Journal:  Mycopathologia       Date:  2012-02-22       Impact factor: 2.574

2.  In vitro activity of amphotericin B, fluconazole and voriconazole against 162 Cryptococcus neoformans isolates from Africa and Cambodia.

Authors:  J Chandenier; K D Adou-Bryn; C Douchet; B Sar; M Kombila; D Swinne; M Thérizol-Ferly; Y Buisson; D Richard-Lenoble
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-05-13       Impact factor: 3.267

3.  Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing proposed standard and the E-test with the NCCLS broth microdilution method for voriconazole and caspofungin susceptibility testing of yeast species.

Authors:  Erja Chryssanthou; Manuel Cuenca-Estrella
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.